Virax Biolabs

1.22
开盘价
1.24
市值
972.33K+
最高价
1.27
最低价
1.20
收盘价
1.22
成交量
33.87K+
市盈率
-0.10
股息率
0.00%

Virax Biolabs简介

Virax Biolabs Group Ltd 是一家创新型生物技术公司,专注于病毒性疾病的预防、检测、诊断和风险管理,还从事各种病毒威胁的诊断检测试剂盒的分销。该公司正在开发一种专有的 T 细胞检测技术,旨在提供一个免疫学分析平台,评估每个人对全球主要病毒威胁的免疫风险状况。T 细胞检测在诊断和治疗 COVID-19 以及包括乙型肝炎、疟疾、疱疹和人类乳头瘤病毒在内的其他病毒威胁方面特别有效。

如何购买 Virax Biolabs (VRAX)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 VRAX

购买 VRAX

通过 RockFlow App 或网页端搜索 VRAX,输入您想要投资的金额,然后点击确认即可完成交易。

logo

社交媒体

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.